United Therapeutics Current Ratio 2006-2020 | UTHR

Current and historical current ratio for United Therapeutics (UTHR) from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. United Therapeutics current ratio for the three months ending March 31, 2020 was 8.91.
United Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $1.85B $0.21B 8.91
2019-12-31 $1.87B $0.46B 4.03
2019-09-30 $1.93B $0.47B 4.11
2019-06-30 $2.14B $0.46B 4.62
2019-03-31 $1.94B $0.27B 7.19
2018-12-31 $1.77B $0.28B 6.39
2018-09-30 $1.61B $0.37B 4.32
2018-06-30 $1.62B $0.35B 4.64
2018-03-31 $1.63B $0.32B 5.13
2017-12-31 $1.45B $0.45B 3.26
2017-09-30 $1.64B $0.79B 2.08
2017-06-30 $1.56B $0.84B 1.86
2017-03-31 $1.50B $0.43B 3.52
2016-12-31 $1.43B $0.33B 4.29
2016-09-30 $1.39B $0.32B 4.41
2016-06-30 $1.32B $0.29B 4.50
2016-03-31 $1.30B $0.36B 3.64
2015-12-31 $1.28B $0.44B 2.89
2015-09-30 $1.23B $0.56B 2.20
2015-06-30 $0.83B $0.54B 1.53
2015-03-31 $0.99B $0.65B 1.54
2014-12-31 $0.96B $0.50B 1.90
2014-09-30 $1.08B $0.76B 1.42
2014-06-30 $0.88B $0.66B 1.34
2014-03-31 $0.99B $0.66B 1.50
2013-12-31 $0.91B $0.69B 1.33
2013-09-30 $0.93B $0.47B 1.99
2013-06-30 $0.90B $0.41B 2.19
2013-03-31 $0.85B $0.18B 4.78
2012-12-31 $0.67B $0.18B 3.78
2012-09-30 $0.72B $0.23B 3.16
2012-06-30 $0.57B $0.19B 3.04
2012-03-31 $0.57B $0.18B 3.27
2011-12-31 $0.56B $0.21B 2.65
2011-09-30 $0.85B $0.43B 1.99
2011-06-30 $0.88B $0.45B 1.94
2011-03-31 $0.81B $0.44B 1.84
2010-12-31 $0.76B $0.43B 1.78
2010-09-30 $0.60B $0.40B 1.51
2010-06-30 $0.52B $0.37B 1.41
2010-03-31 $0.40B $0.33B 1.21
2009-12-31 $0.33B $0.33B 0.98
2009-09-30 $0.32B $0.30B 1.07
2009-06-30 $0.29B $0.08B 3.78
2009-03-31 $0.27B $0.06B 4.47
2008-12-31 $0.30B $0.06B 5.16
2008-09-30 $0.30B $0.29B 1.01
2008-06-30 $0.28B $0.29B 0.96
2008-03-31 $0.33B $0.06B 5.42
2007-12-31 $0.35B $0.27B 1.29
2007-09-30 $0.29B $0.03B 8.75
2007-06-30 $0.25B $0.02B 10.59
2007-03-31 $0.22B $0.02B 11.39
2006-12-31 $0.28B $0.02B 14.41
2006-09-30 $0.18B $0.02B 9.01
2006-06-30 $0.21B $0.02B 8.69
2006-03-31 $0.19B $0.02B 10.54
2005-12-31 $0.17B $0.02B 11.48
2005-09-30 $0.15B $0.02B 8.58
2005-06-30 $0.13B $0.02B 8.04
2005-03-31 $0.12B $0.01B 10.01
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.146B $1.449B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.390B 37.11
Takeda Pharmaceutical (TAK) Japan $54.479B 9.55
Astellas Pharma (ALPMY) Japan $29.584B 14.99
Eisai (ESALY) Japan $24.627B 21.35
UCB SA (UCBJF) Belgium $23.856B 0.00
Merck (MKGAF) Germany $16.075B 21.08
Grifols, S.A (GRFS) Spain $12.802B 15.91
Catalent (CTLT) United States $12.260B 47.40
Neurocrine Biosciences (NBIX) United States $12.217B 56.46
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.421B 44.77
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.936B 31.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.837B 9.34
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.595B 501.67
Nektar Therapeutics (NKTR) United States $4.348B 0.00
Evotec AG (EVTCY) Germany $4.090B 110.22
Hypermarcas (HYPMY) Brazil $3.793B 13.95
FibroGen (FGEN) United States $3.726B 0.00
PTC Therapeutics (PTCT) United States $3.724B 0.00
ChemoCentryx (CCXI) United States $3.654B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.493B 10.24
Pacira BioSciences (PCRX) United States $2.423B 49.59
Sage Therapeutics (SAGE) United States $2.290B 0.00
Cronos Group (CRON) Canada $2.100B 60.20
Corcept Therapeutics (CORT) United States $1.920B 19.03
Xencor (XNCR) United States $1.821B 0.00
USANA Health Sciences (USNA) United States $1.725B 17.69
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.719B 0.00
Akebia Therapeutics (AKBA) United States $1.628B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.571B 12.02
Indivior (INVVY) United States $1.556B 19.31
Zogenix (ZGNX) United States $1.539B 0.00
Esperion Therapeutics (ESPR) United States $1.428B 0.00
Heron Therapeutics (HRTX) United States $1.419B 0.00
Karyopharm Therapeutics (KPTI) United States $1.378B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.351B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.306B 14.06
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.080B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.022B 45.63
BioCryst Pharmaceuticals (BCRX) United States $0.975B 0.00
Tilray (TLRY) Canada $0.925B 0.00
ImmunoGen (IMGN) United States $0.841B 0.00
Endo (ENDP) Ireland $0.772B 1.20
Radius Health (RDUS) United States $0.616B 0.00
VAXART, INC (VXRT) United States $0.608B 0.00
Trillium Therapeutics (TRIL) Canada $0.603B 0.00
Aerie Pharmaceuticals (AERI) United States $0.603B 0.00
Molecular Templates (MTEM) United States $0.596B 0.00
Collegium Pharmaceutical (COLL) United States $0.589B 0.00
Ardelyx (ARDX) United States $0.587B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.558B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.519B 12.55
Crinetics Pharmaceuticals (CRNX) United States $0.512B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 18.35
Flexion Therapeutics (FLXN) United States $0.469B 0.00
Siga Technologies (SIGA) United States $0.462B 0.00
DURECT (DRRX) United States $0.425B 0.00
Harpoon Therapeutics (HARP) United States $0.403B 0.00
TherapeuticsMD (TXMD) United States $0.399B 0.00
Ocular Therapeutix (OCUL) United States $0.398B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.386B 0.00
Calithera Biosciences (CALA) United States $0.368B 0.00
MEI Pharma (MEIP) United States $0.365B 0.00
Organogenesis Holdings (ORGO) United States $0.352B 0.00
Altimmune (ALT) United States $0.314B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.307B 0.00
Concert Pharmaceuticals (CNCE) United States $0.302B 0.00
PROFOUND MEDICL (PROF) Canada $0.287B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.286B 0.00
Taiwan Liposome (TLC) Taiwan $0.256B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.47
Oasmia Pharmaceutical AB (OASMY) Sweden $0.248B 0.00
Redhill Biopharma (RDHL) Israel $0.242B 0.00
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 5.19
KalVista Pharmaceuticals (KALV) United States $0.216B 0.00
Rafael Holdings (RFL) United States $0.196B 0.00
OptiNose (OPTN) United States $0.195B 0.00
IMV INC (IMV) Canada $0.181B 0.00
Nivalis Therapeutics (ALPN) United States $0.176B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 23.08
Aquestive Therapeutics (AQST) United States $0.152B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.140B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.134B 0.00
Otonomy (OTIC) United States $0.119B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
MediWound (MDWD) Israel $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.102B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.100B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Xeris Pharmaceuticals (XERS) United States $0.097B 0.00
CTI BioPharma (CTIC) United States $0.095B 0.00
Onconova Therapeutics (ONTX) United States $0.094B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
Hemispherx BioPharma (AIM) United States $0.087B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Sundial Growers (SNDL) Canada $0.085B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Heat Biologics (HTBX) United States $0.079B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Lipocine (LPCN) United States $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.09
PolarityTE (PTE) United States $0.048B 0.00
IsoRay (ISR) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 7.56
Opiant Pharmaceuticals (OPNT) United States $0.040B 84.54
Novan (NOVN) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Jaguar Animal Health (JAGX) United States $0.038B 0.00
GTx (ONCT) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.14
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00